Home » Stocks » USANA Health Sciences

USANA Health Sciences, Inc. (USNA)

Stock Price: $83.15 USD -0.54 (-0.65%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.75B
Revenue (ttm) 1.06B
Net Income (ttm) 109.51M
Shares Out 21.02M
EPS (ttm) 5.06
PE Ratio 16.43
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $83.15
Previous Close $83.69
Change ($) -0.54
Change (%) -0.65%
Day's Open 83.36
Day's Range 82.26 - 83.43
Day's Volume 52,017
52-Week Range 43.01 - 92.26

More Stats

Market Cap 1.75B
Enterprise Value 1.52B
Earnings Date (est) Oct 27, 2020
Ex-Dividend Date n/a
Shares Outstanding 21.02M
Float 10.32M
EPS (basic) 5.06
EPS (diluted) 5.06
FCF / Share 7.10
Dividend n/a
Dividend Yield n/a
Earnings Yield 6.09%
FCF Yield 8.54%
Payout Ratio n/a
Shares Short 996,849
Short Ratio 5.70
Short % of Float 8.86%
Beta 0.94
PE Ratio 16.43
Forward PE n/a
P/FCF Ratio 11.71
PS Ratio 1.65
PB Ratio 5.05
Revenue 1.06B
Operating Income 158.63M
Net Income 109.51M
Free Cash Flow 149.23M
Net Cash 227.37M
Net Cash / Share 10.82
Gross Margin 82.59%
Operating Margin 15.00%
Profit Margin 10.40%
FCF Margin 14.11%
ROA 18.98%
ROE 29.87%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$97.50*
(17.26% upside)
Low
85.0
Current: $83.15
High
110.0
Target: 97.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1,0611,1891,0471,006918790718649582518
Revenue Growth-10.79%13.56%4.09%9.54%16.2%10.07%10.71%11.48%12.42%-
Gross Profit873989868826759650591533480422
Operating Income14618813313914211611798.1877.2668.22
Net Income10112662.5410094.6776.6479.0266.4350.7545.65
Shares Outstanding22.6424.1124.3524.1925.4626.4427.3929.0930.7231.06
Earnings Per Share4.415.122.533.993.592.802.782.231.631.43
EPS Growth-13.87%102.37%-36.59%11.14%28.21%0.72%24.94%36.5%13.99%-
Operating Cash Flow12715212413711110598.8992.8170.1166.11
Capital Expenditures-16.55-11.05-13.20-32.69-23.54-20.41-8.00-8.28-10.61-4.16
Free Cash Flow11014111110487.9284.7790.8984.5359.5061.95
Cash & Equivalents23527824717614311114670.8450.3524.22
Net Cash / Debt23527824717614311114670.8450.3524.22
Assets517554519471423351368267244217
Liabilities16516315614514212010881.7870.5969.83
Book Value352391363325281230261186174147
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name USANA Health Sciences, Inc.
Country United States
Employees 1,909
CEO Kevin G. Guest

Stock Information

Ticker Symbol USNA
Stock Exchange New York Stock Exchange
Sector Consumer Defensive
Industry Household & Personal Products
Unique Identifier NYSE: USNA
IPO Date July 25, 1996

Description

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.